1887

Abstract

Human immunodeficiency virus type 1 (HIV-1) Tat and human Cyclin T1 form a complex and together recognize the viral TAR RNA element with specificity. Using HIV-1/equine infectious anaemia virus TAR chimeras, we show that in addition to the well-characterized interaction with the bulge, Tat recognizes the distal stem and the loop of TAR. These data support previously proposed, but unproven, molecular models.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18645-0
2003-03-01
2020-01-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/3/vir840603.html?itemId=/content/journal/jgv/10.1099/vir.0.18645-0&mimeType=html&fmt=ahah

References

  1. Albrecht, T. R., Lund, L. H. & Garcia-Blanco, M. A. ( 2000; ). Canine cyclin T1 rescues equine infectious anemia virus Tat trans-activation in human cells. Virology 268, 7–11.[CrossRef]
    [Google Scholar]
  2. Bieniasz, P. D., Grdina, T. A., Bogerd, H. P. & Cullen, B. R. ( 1998; ). Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J 17, 7056–7065.[CrossRef]
    [Google Scholar]
  3. Bieniasz, P. D., Grdina, T. A., Bogerd, H. P. & Cullen, B. R. ( 1999; ). Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism. Mol Cell Biol 19, 4592–4599.
    [Google Scholar]
  4. Carroll, R., Peterlin, B. M. & Derse, D. ( 1992; ). Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans activators. J Virol 66, 2000–2007.
    [Google Scholar]
  5. Carvalho, M. & Derse, D. ( 1991; ). Mutational analysis of the equine infectious anemia virus Tat-responsive element. J Virol 65, 3468–3474.
    [Google Scholar]
  6. Churcher, M. J., Lamont, C., Hamy, F., Dingwall, C., Green, S. M., Lowe, A. D., Butler, J. G., Gait, M. J. & Karn, J. ( 1993; ). High affinity binding of TAR RNA by the human immunodeficiency virus type-1 Tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J Mol Biol 230, 90–110.[CrossRef]
    [Google Scholar]
  7. Colvin, R. A. & Garcia-Blanco, M. A. ( 1992; ). Unusual structure of the human immunodeficiency virus type 1 trans-activation response element. J Virol 66, 930–935.
    [Google Scholar]
  8. Colvin, R. A., White, S. W., Garcia-Blanco, M. A. & Hoffman, D. W. ( 1993; ). Structural features of an RNA containing the CUGGGA loop of the human immunodeficiency virus type 1 trans-activation response element. Biochemistry 32, 1105–1112.[CrossRef]
    [Google Scholar]
  9. Cullen, B. R. ( 1998; ). HIV-1 auxiliary proteins: making connections in a dying cell. Cell 93, 685–692.[CrossRef]
    [Google Scholar]
  10. Farrow, M. A., Aboul-ela, F., Owen, D., Karpeisky, A., Beigelman, L. & Gait, M. J. ( 1998; ). Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes. Biochemistry 37, 3096–3108.[CrossRef]
    [Google Scholar]
  11. Feng, S. & Holland, E. C. ( 1988; ). HIV-1 Tat trans-activation requires the loop sequence within Tar. Nature 334, 165–167.[CrossRef]
    [Google Scholar]
  12. Garber, M. E., Wei, P., KewalRamani, V. N., Mayall, T. P., Herrmann, C. H., Rice, A. P., Littman, D. R. & Jones, K. A. ( 1998a; ). The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes & Dev 12, 3512–3527.[CrossRef]
    [Google Scholar]
  13. Garber, M. E., Wei, P. & Jones, K. A. ( 1998b; ). HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA. Cold Spring Harbor Symp Quant Biol 63, 371–380.[CrossRef]
    [Google Scholar]
  14. Hoffman, D. W. & White, S. W. ( 1995; ). NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus. Nucleic Acids Res 23, 4058–4065.[CrossRef]
    [Google Scholar]
  15. Hoffman, D. W., Colvin, R. A., Garcia-Blanco, M. A. & White, S. W. ( 1993; ). Structural features of the trans-activation response RNA element of equine infectious anemia virus. Biochemistry 32, 1096–1104.[CrossRef]
    [Google Scholar]
  16. Huq, I. & Rana, T. M. ( 1997; ). Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat–TAR complex by affinity cleaving. Biochemistry 36, 12592–12599.[CrossRef]
    [Google Scholar]
  17. Loret, E. P., Georgel, P., Johnson, W. C., Jr & Ho, P. S. ( 1992; ). Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator. Proc Natl Acad Sci U S A 89, 9734–9738.[CrossRef]
    [Google Scholar]
  18. Puglisi, J. D., Chen, L., Blanchard, S. & Frankel, A. D. ( 1995; ). Solution structure of a bovine immunodeficiency virus Tat–TAR peptide–RNA complex. Science 270, 1200–1203.[CrossRef]
    [Google Scholar]
  19. Suñe, C. & Garcia-Blanco, M. A. ( 1999; ). Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner. Mol Cell Biol 19, 4719–4728.
    [Google Scholar]
  20. Taube, R., Fujinaga, K., Irwin, D., Wimmer, J., Geyer, M. & Peterlin, B. M. ( 2000; ). Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. J Virol 74, 892–898.[CrossRef]
    [Google Scholar]
  21. Wang, Z., Huq, I. & Rana, T. M. ( 1999; ). Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking. Bioconjug Chem 10, 512–519.[CrossRef]
    [Google Scholar]
  22. Wei, P., Garber, M. E., Fang, S., Fischer, W. H. & Jones, K. A. ( 1998; ). A novel CDK9 associated c-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92, 451–462.[CrossRef]
    [Google Scholar]
  23. Zhang, J., Tamilarasu, N., Hwang, S., Garber, M. E., Huq, I., Jones, K. A. & Rana, T. M. ( 2000; ). HIV-1 TAR RNA enhances the interaction between Tat and cylin T1. J Biol Chem 275, 3431–3439.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18645-0
Loading
/content/journal/jgv/10.1099/vir.0.18645-0
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error